Lobbyists Suspect Grassley May Ax Inflation Rebates From Drug Bill

By John Wilkerson / June 30, 2020 at 2:59 PM
Senate Finance Committee Chair Chuck Grassley plans to introduce “in the coming days” an updated version of his drug pricing legislation, and the Iowa Republican now blames Democrats, who voted for his bill in committee, for not negotiating on changes. Some lobbyists suspect Grassley might eliminate inflationary rebates -- the bill’s main provision to curb drug prices -- to gain Republican support, but Grassley’s office declined to comment on the rumor. That no-comment response contrasts with Grassley repeated promises over...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.